Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 92.59
(-0.42%)
CNY 92.59
(-0.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 210.88 Million CNY | 35.21% |
| 2022 | 155.97 Million CNY | 45.88% |
| 2021 | 106.91 Million CNY | 30.3% |
| 2020 | 82.05 Million CNY | 45.77% |
| 2019 | 56.29 Million CNY | 66.93% |
| 2018 | 33.72 Million CNY | 30.21% |
| 2017 | 25.89 Million CNY | 7.46% |
| 2016 | 24.1 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 205.28 Million CNY | -2.65% |
| 2024 Q2 | 200.25 Million CNY | -2.45% |
| 2024 Q3 | 270.28 Million CNY | 34.97% |
| 2023 Q4 | 210.88 Million CNY | -1.91% |
| 2023 FY | 210.88 Million CNY | 35.21% |
| 2023 Q3 | 214.98 Million CNY | 12.4% |
| 2023 Q2 | 191.27 Million CNY | 6.83% |
| 2023 Q1 | 179.04 Million CNY | 14.79% |
| 2022 Q4 | 155.97 Million CNY | 16.93% |
| 2022 Q3 | 133.39 Million CNY | 19.55% |
| 2022 Q2 | 111.57 Million CNY | 6.88% |
| 2022 Q1 | 104.39 Million CNY | -2.36% |
| 2022 FY | 155.97 Million CNY | 45.88% |
| 2021 FY | 106.91 Million CNY | 30.3% |
| 2021 Q1 | 87.19 Million CNY | 6.26% |
| 2021 Q2 | 91.89 Million CNY | 5.39% |
| 2021 Q3 | 100.52 Million CNY | 9.39% |
| 2021 Q4 | 106.91 Million CNY | 6.36% |
| 2020 Q1 | 61.41 Million CNY | 9.1% |
| 2020 Q4 | 82.05 Million CNY | 8.52% |
| 2020 Q3 | 75.61 Million CNY | 12.41% |
| 2020 Q2 | 67.26 Million CNY | 9.53% |
| 2020 FY | 82.05 Million CNY | 45.77% |
| 2019 Q4 | 56.29 Million CNY | 12.44% |
| 2019 Q3 | 50.06 Million CNY | 23.69% |
| 2019 FY | 56.29 Million CNY | 66.93% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 40.47 Million CNY | 0.0% |
| 2018 Q4 | 33.72 Million CNY | 0.0% |
| 2018 FY | 33.72 Million CNY | 30.21% |
| 2017 FY | 25.89 Million CNY | 7.46% |
| 2016 FY | 24.1 Million CNY | 0.0% |